Efficacy of buspirone in alcohol dependence: A review

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 5, 1996, Pages 853-858

  Malec, T S ^a   Malec, E A ^a   Dongier, Mayrice ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alcoholism; Buspirone; Efficacy; Metaanalysis; Treatment

Indexed keywords

BUSPIRONE;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY NEUROSIS; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029834689     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb05263.x     Document Type: Article

References (39)

1. Project MATCH (Matching Alcoholism Treatment to Client Heterogeneity): Rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcohol Clin Exp Res 17:1130-1145, 1993
2. Tabakoff B, Hoffman PL: Biochemical pharmacology of alcohol, in Meltzer HY (ed): Pharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1521-1526
3. Sciorato F, Moser J, Poinso Y: Acamprosate et aide au maintien de l'abstinence: Résultats cliniques actuels. Psychol Méd 26:594-603, 1994
4. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
5. O'Malley SS, Jaffe A, Chang G, Witte G, Shottenfeld RS, Meyer RE, Rounsaville BJ: Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881-887, 1992
6. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K: The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41:266-274, 1987
7. Eison MS: The new generation of serotonergic anxiolytics: Possible clinical roles. Psychopathology 22(Suppl. 1):13-20, 1989
8. Riblet LA, Eison AS, Eison MS, Taylor DP, Van der Mealen CP: Neuropharmacology of buspirone. Psychopathology 17(Suppl. 3):60-78, 1984
9. Goa K, Ward A: Buspirone: A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32: 115-129, 1986
10. Lydiard RB, Howell EF, Ballenger JC, Malcolm R: Prevalence of anxiety and mood disorders in hospitalized alcoholics. Presented at the American College of Neuropsychopharmacology Meeting, San Juan, Puerto Rico, 1989
11. Helzer JE, Pryzbeck TR: The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 49:219-224, 1988
12. Powell BJ, Perich EC, Othomer E: Prevalence of additional psychiatric syndromes among male alcoholics. J Clin Psychiatry 43:404-407, 1982
13. Bowen RC, Cipywnyk D, D'Aray CM, Keegan D: Alcoholism, anxiety disorders and agoraphobia. Alcohol Clin Exp Res 8:48-50, 1984
14. Weiss KJ, Rosenberg DJ: Prevalence of anxiety disorders among alcoholics. J Clin Psychiatry 46:3-4, 1985
15. Smail P, Stockwell T, Canter S, Hodgson R: Alcohol dependence and phobic anxiety states. I. A prevalence study. Br J Psychiatry 144:53-57, 1984
16. Quitkin RM, Rifkin A, Kaplan JF: Phobic anxiety syndrome complicated by drug dependence and addiction: A treatable form of drug abuse. Arch Gen Psychiatry 27:154-162, 1972
17. Weissman MM, Myers JK, Harding PS: Prevalence and psychiatric heterogeneity of alcoholism in a United States urban community. J Stud Alcohol 41:672-681, 1980
18. Brown SA, Irwin M, Schuckit MA: Changes in anxiety among abstinent male alcoholics. J Stud Alcohol 52:55-61, 1991
19. Goldberg HL, Finnerty R: Comparison of buspirone in two separate studies. J Clin Psychiatry 43:87-91, 1982
20. Pecknold JC, Matas M, Howarth BG, Ross C, Swinson R, Vezeau C, Ungar W: Evaluation of buspirone as an antianxiety agent: Buspirone and diazepam versus placebo. Can J Psychiatry 34:766-771, 1989
21. Collins DM, Myers RD: Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol 4:49-56, 1987
22. Cohn JB, Bowden CL, Fisher JG, Rodos JJ: Double blind comparison of buspirone and clorazepate in anxious outpatients. Am J Med 80(Suppl. 3B):10-16, 1986
23. Fontaine R, Beaudry P, Beauclair L, Chouinard G: Comparison of withdrawal of buspirone and diazepam: A placebo controlled study. Prog Neuropsychopharmacol Biol Psychiatry 11:189-197, 1987
24. Rickels K, Schweizer E, Csanalosi I, et al: Long-term treatment of anxiety and risk of withdrawal: Prospective comparison of clorazepate and buspirone. Arch Gen Psychiatry 45:444-450, 1988
25. Cole JO, Orzack MH, Beake B, Bird M, Bar-Ta Y: Assessment of the abuse liability of buspirone in recreational sedative users. J Clin Psychiatry 43:69-74, 1982
26. Smiley A, Moskowitz H: Effects of long-term administration of buspirone and diazepam on driver steering control. Am J Med 80:22-29, 1986
27. Schaffler K, Klausnitzer W: Single dose study on buspirone versus diazepam in volunteers: Monitoring psychomotor performance via oculomotor, choice reaction and electromyographic parameters. Arzneim-Forsch/Drug Res 38:282-287, 1988
28. Privette TH, Hornsby RI, Myers RD: Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol 5:147-152, 1988
29. Kranzler HR, Meyer RE: An open trial of buspirone in alcoholics. J Clin Psychopharmacol 9:379-380, 1989
30. Olivera AA, Sarvis S, Heard C: Anxiety disorders coexisting with substance dependence: Treatment with buspirone. Curr Ther Res Clin Exp 47:52-61, 1990
31. Bruno F: Buspirone in the treatment of alcoholic patients. Psychopathology 22(Suppl. 1):49-59, 1989
32. Tollefson GD, Montague-Clouse J, Tollefson SL: Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12:19-26, 1992
33. Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A: A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16:1007-1013, 1992
34. Kranzler HR, Burleson JA, DelBoca FK, Babor TF, Korner P, Brown J, Bohn MJ: Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry 51:720-731, 1994
35. Malec E, Malec T, Gagné MA, Dongier M: Buspirone in the treatment of alcohol dependence: A placebo-controlled trial. Alcohol Clin Exp Res 20:307-312, 1996
36. Sacket DL, Gent M: Controversy in counting an attributing events in clinical trials. N Engl J Med 301:1410-1412, 1979
37. Feighner JP, Meredith CH, Hendrickson GA: A double-blind comparison of buspirone and diazepam in outpatients with generalised anxiety disorder. J Clin Psychiatry 43:103-107, 1982
38. Powell BJ, Campbell JL, Landon JF, et al: A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. Alcohol Clin Exp Res 19:462-468, 1995
39. Dongier M, Vachon L, Schwartz G: Bromocriptine in the treatment of alcohol dependence. Alcohol Clin Exp Res 15:970-977, 1991